Cargando…

Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry

BACKGROUND: Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient w...

Descripción completa

Detalles Bibliográficos
Autores principales: Oono, Miki, Fujita, Yoshimasa, Uchida, Nobuaki, Kawai, Ukichiro, Fujita-Nakata, Michiyo, Nakanishi, Megumi, Sanada, Mitsuru, Nagayama, Shigemi, Matsui, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960130/
https://www.ncbi.nlm.nih.gov/pubmed/29776427
http://dx.doi.org/10.1186/s12974-018-1196-3
_version_ 1783324531069288448
author Oono, Miki
Fujita, Yoshimasa
Uchida, Nobuaki
Kawai, Ukichiro
Fujita-Nakata, Michiyo
Nakanishi, Megumi
Sanada, Mitsuru
Nagayama, Shigemi
Matsui, Makoto
author_facet Oono, Miki
Fujita, Yoshimasa
Uchida, Nobuaki
Kawai, Ukichiro
Fujita-Nakata, Michiyo
Nakanishi, Megumi
Sanada, Mitsuru
Nagayama, Shigemi
Matsui, Makoto
author_sort Oono, Miki
collection PubMed
description BACKGROUND: Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient with RM using flow cytometry. CASE PRESENTATION: A 36-year-old woman with RA and generalized myasthenia gravis (MG) developed RM during a remission phase. Although both RA and MG were stable and well controlled, she noticed fever, headache, and transient sensory disturbance. Blood and CSF examination findings suggested aseptic meningitis, while brain magnetic resonance imaging revealed restricted portions of meningitis and associated cortical lesions, compatible with a diagnosis of RM. The dose of oral prednisolone was increased, which ameliorated the symptoms within 1 week along with improvement in CSF findings. This patient exhibited features of RM that were manifested in a manner independent of the activity of RA. An investigation of cellular immunity using CSF specimens with flow cytometry showed differences in regard to the pathogenesis of inflammation in the CSF as compared to outside of the central nervous system. In contrast to results obtained with paired blood samples, CSF cells at the peak stage of RM showed a marked increase in CCR3(+) Th2 cells and marked decrease in CD8(+) cells, suggesting an immunoregulatory disturbance in the CSF. Those findings indicated a CSF-specific activation of humoral immunity, resulting in augmentation of meningeal inflammation, as shown by excess synthesis of intrathecal IgG and markedly elevated interleukin-6 level. Results of the present detailed investigation of lymphocyte subsets revealed a discrepancy regarding the process of inflammation in this RM patient between CSF and blood samples. CONCLUSIONS: RM is not a simple reflection of the immune status of RA, as the pathogenesis seems related to, at least in part, CSF-specific immunological dysregulation.
format Online
Article
Text
id pubmed-5960130
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59601302018-05-24 Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry Oono, Miki Fujita, Yoshimasa Uchida, Nobuaki Kawai, Ukichiro Fujita-Nakata, Michiyo Nakanishi, Megumi Sanada, Mitsuru Nagayama, Shigemi Matsui, Makoto J Neuroinflammation Case Report BACKGROUND: Rheumatoid meningitis (RM) is a rare disorder that often develops during a remission phase of rheumatoid arthritis (RA). This is the first study to demonstrate differences in regard to immunological disturbance between blood and cerebrospinal fluid (CSF) samples obtained from a patient with RM using flow cytometry. CASE PRESENTATION: A 36-year-old woman with RA and generalized myasthenia gravis (MG) developed RM during a remission phase. Although both RA and MG were stable and well controlled, she noticed fever, headache, and transient sensory disturbance. Blood and CSF examination findings suggested aseptic meningitis, while brain magnetic resonance imaging revealed restricted portions of meningitis and associated cortical lesions, compatible with a diagnosis of RM. The dose of oral prednisolone was increased, which ameliorated the symptoms within 1 week along with improvement in CSF findings. This patient exhibited features of RM that were manifested in a manner independent of the activity of RA. An investigation of cellular immunity using CSF specimens with flow cytometry showed differences in regard to the pathogenesis of inflammation in the CSF as compared to outside of the central nervous system. In contrast to results obtained with paired blood samples, CSF cells at the peak stage of RM showed a marked increase in CCR3(+) Th2 cells and marked decrease in CD8(+) cells, suggesting an immunoregulatory disturbance in the CSF. Those findings indicated a CSF-specific activation of humoral immunity, resulting in augmentation of meningeal inflammation, as shown by excess synthesis of intrathecal IgG and markedly elevated interleukin-6 level. Results of the present detailed investigation of lymphocyte subsets revealed a discrepancy regarding the process of inflammation in this RM patient between CSF and blood samples. CONCLUSIONS: RM is not a simple reflection of the immune status of RA, as the pathogenesis seems related to, at least in part, CSF-specific immunological dysregulation. BioMed Central 2018-05-18 /pmc/articles/PMC5960130/ /pubmed/29776427 http://dx.doi.org/10.1186/s12974-018-1196-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Oono, Miki
Fujita, Yoshimasa
Uchida, Nobuaki
Kawai, Ukichiro
Fujita-Nakata, Michiyo
Nakanishi, Megumi
Sanada, Mitsuru
Nagayama, Shigemi
Matsui, Makoto
Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_full Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_fullStr Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_full_unstemmed Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_short Rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
title_sort rheumatoid meningitis developed in patient with stable rheumatoid arthritis and myasthenia gravis—detailed analysis of intracranial inflammation using flow cytometry
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960130/
https://www.ncbi.nlm.nih.gov/pubmed/29776427
http://dx.doi.org/10.1186/s12974-018-1196-3
work_keys_str_mv AT oonomiki rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT fujitayoshimasa rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT uchidanobuaki rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT kawaiukichiro rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT fujitanakatamichiyo rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT nakanishimegumi rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT sanadamitsuru rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT nagayamashigemi rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry
AT matsuimakoto rheumatoidmeningitisdevelopedinpatientwithstablerheumatoidarthritisandmyastheniagravisdetailedanalysisofintracranialinflammationusingflowcytometry